According to a new report Asia Pacific Spirulina Market, published by KBV research, the Asia Pacific Spirulina Market would witness market growth of 12% CAGR during the forecast period (2019-2025).
The China market dominated the Asia Pacific Arthrospira Maxima Market by Region in 2018, growing at a CAGR of 12.1 % during the forecast period. The Japan market is expected to witness a CAGR of 15.4% during (2019 - 2025). Additionally, The India market is expected to witness a CAGR of 15.5% during (2019 - 2025).
The Powder market dominated the Asia Pacific Spirulina Market by Drug Formulation in 2018, growing at a CAGR of 11.3 % during the forecast period. The Tablet & Capsule market is expected to witness highest CAGR of 11.5% during (2019 - 2025).
The Nutraceuticals market dominated the South Korea Spirulina Market by Application in 2018, thereby, achieving a market value of $5 Million by 2025, growing at a CAGR of 11.7 % during the forecast period. The Cosmetics market is expected to witness a CAGR of 14.8% during (2019 - 2025).
Full Report: https://www.kbvresearch.com/asia-pacific-spirulina-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Cyanotech Corporation, DIC Corporation, Chr. Hansen Holding A/S, Algenol, LLC, Prolgae Spirulina Supplies Pvt. Ltd., Sensient Technologies Corporation, DDW, Inc., GNC Holdings, Inc., NOW Foods, Inc. and Sunrise Nutrachem Group Co. Ltd.
By Type
By Application
By Drug Formulation
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
